- Home
- VRPX vs NDRA Comparison
VRPX vs NDRA Comparison
Compare VRPX & NDRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRPX
- NDRA
- Stock Information
- Founded
- VRPX 2016
- NDRA 2007
- Country
- VRPX United States
- NDRA United States
- Employees
- VRPX N/A
- NDRA N/A
- Industry
- VRPX Medicinal Chemicals and Botanical Products
- NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- VRPX Health Care
- NDRA Health Care
- Exchange
- VRPX Nasdaq
- NDRA Nasdaq
- Market Cap
- VRPX 3.7M
- NDRA 3.6M
- IPO Year
- VRPX 2021
- NDRA 2017
- Fundamental
- Price
- VRPX $0.30
- NDRA $6.01
- Analyst Decision
- VRPX Hold
- NDRA Strong Buy
- Analyst Count
- VRPX 1
- NDRA 1
- Target Price
- VRPX N/A
- NDRA $14,000.00
- AVG Volume (30 Days)
- VRPX 1.1M
- NDRA 36.2K
- Earning Date
- VRPX 11-14-2024
- NDRA 11-15-2024
- Dividend Yield
- VRPX N/A
- NDRA N/A
- EPS Growth
- VRPX N/A
- NDRA N/A
- EPS
- VRPX N/A
- NDRA N/A
- Revenue
- VRPX N/A
- NDRA N/A
- Revenue This Year
- VRPX N/A
- NDRA N/A
- Revenue Next Year
- VRPX N/A
- NDRA N/A
- P/E Ratio
- VRPX N/A
- NDRA N/A
- Revenue Growth
- VRPX N/A
- NDRA N/A
- 52 Week Low
- VRPX $0.29
- NDRA $4.01
- 52 Week High
- VRPX $5.48
- NDRA $2,240.00
- Technical
- Relative Strength Index (RSI)
- VRPX 37.37
- NDRA 51.58
- Support Level
- VRPX $0.33
- NDRA $5.60
- Resistance Level
- VRPX $0.36
- NDRA $6.29
- Average True Range (ATR)
- VRPX 0.04
- NDRA 0.60
- MACD
- VRPX -0.00
- NDRA 0.02
- Stochastic Oscillator
- VRPX 6.22
- NDRA 27.29
About VRPX Virpax Pharmaceuticals Inc.
Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray.
About NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI but at 1/50th the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.